01 1Signa S.A. de C.V.
01 1SITAGLIPTIN PHOSPHATE MONOHYDRATE USP
01 1Mexico
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-12
Pay. Date : 2017-12-05
DMF Number : 32298
Submission : 2018-03-30
Status : Active
Type : II
20
Signa Sa De Cv, based in Mexico, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SITAGLIPTIN PHOSPHATE MONOHYDRATE USP, with a corresponding US DMF Number 32298.
Remarkably, this DMF maintains an Active status since its submission on March 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 12, 2018, and payment made on December 05, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
